Endovascular Management of Mycotic Pseudoaneurysm After Pancreas Transplantation: Case Report and Literature Review.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 09 06 2019
revised: 06 08 2019
accepted: 26 09 2019
pubmed: 23 2 2020
medline: 6 8 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

Mycotic pseudoaneurysm is a rare complication of pancreas transplantation. Successful management relies on early diagnosis and expedient treatment comprising surgery and antibiotics. While the standard of care in recipients of pancreatic transplants is open repair of pseudoaneurysm with or without excision of the allograft, endovascular management has been reported. Endovascular repair is a less invasive treatment option with advantages of expedient control of hemorrhage, avoidance of adhesions with an open repair, and greater suitability for elderly and frail patients. We report a case of a 40-year-old recipient of a pancreas transplant who had a mycotic pseudoaneurysm managed with endovascular repair. A systematic search of PubMed-MEDLINE, Embase, and Cochrane Library was performed of all cases of mycotic aneurysms following pancreas or kidney transplantation managed with endovascular repair. There were 14 cases of mycotic aneurysms in transplant recipients managed with endovascular repair in the literature. Of those who received an endovascular stent as the only initial management strategy, 6 (54.5%) required a subsequent graft excision. Four (28.6%) patients required excision of their stent due to continued sepsis. There was 1 death from unrelated causes. Endovascular repair was a reasonable bridging technique to further definitive surgical treatment in our case. Endovascular management may be used with caution in high-risk patients. We advocate for prolonged antibiotic therapy combined with vigilant surveillance of the clinical response, and a low threshold for allograft excision in the event of clinical deterioration.

Identifiants

pubmed: 32081354
pii: S0041-1345(19)30899-1
doi: 10.1016/j.transproceed.2019.09.015
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

660-666

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Auteurs

Jinna Yao (J)

Department of Urology, Westmead Hospital, Sydney, Australia; Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.

Mauro Vicaretti (M)

Department of Vascular Surgery, Westmead Hospital, Sydney, Australia.

Taina Lee (T)

Department of Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

Rajith Amaratunga (R)

Department of Surgery, Westmead Hospital, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.

Nicholas Cocco (N)

Department of Surgery, Westmead Hospital, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.

Jerome Laurence (J)

Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia; Department of Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

Natasha Rogers (N)

National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia; Department of Renal Medicine, Westmead Hospital, Sydney, Australia.

Germaine Wong (G)

National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia; Department of Renal Medicine, Westmead Hospital, Sydney, Australia.

Angela Webster (A)

National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia; Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia; Department of Renal Medicine, Westmead Hospital, Sydney, Australia; School of Public Health, University of Sydney, Sydney, Australia.

Wayne Hawthorne (W)

Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.

Howard Lau (H)

Department of Urology, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia.

Richard Allen (R)

Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; Department of Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

Lawrence Yuen (L)

Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.

Henry Pleass (H)

Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia. Electronic address: henry.pleass@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH